Drawing on five years of landscape survey data, ACRO’s RBQM Summary Report outlines the current state of RBM & RBQM adoption in the clinical research industry.
Findings demonstrate that centralized monitoring is still being underutilized, despite the potential for increased patient safety oversight and improved data quality. Download the ACRO RBQM Summary Report for full readout on the latest adoption trends and key takeaways:
Risk-Based Monitoring in Clinical Trials: A 5- Year Summary Report
ACRO’s RBQM Working Group is on a mission to help the industry use centralized monitoring more effectively.
You can find full results, in-depth discussion, and real world use case of centralized monitoring adoption in ACRO’s December 2024 publication, “Risk-Based Quality Management: A Case for Centralized Monitoring.”